SZSE Ticker: 002019

Yifan Pharmaceutical Co., Ltd

亿帆医药股份有限公司

亿帆医药

YIFAN PHARM

Listing Date: 2004-07-13

Board: SME

Industry Classification: Manufacturing

Starting from the growth hormone market of tens of billions, how deep is the "increasing needle"? _Sina Finance_Sina.com

Post date May 13, 2022 — 23:15 Post Lock

Hangyang Co., Ltd. (002430): Proposed change of independent director- CFi.CN China Financial Network

Post date May 13, 2022 — 18:47 Post Lock

Since May, many places in China have successively implemented the results of centralized insulin collection. Listed companies have accelerated the pace of new product development and approval.

Post date May 12, 2022 — 20:59 Post Lock

Ou Weiting’s domestic online debut, JD.com Pharmacy and Yifan Pharmaceutical to create a digital service benchmark – yqqlm

Post date May 9, 2022 — 10:46 Post Lock

Yifan Pharmaceutical: Personnel changes in executives

Post date May 7, 2022 — 00:50 Post Lock

Industry Observations

Post date May 1, 2022 — 23:10 Post Lock

Yifan Pharmaceutical: The decrease in net profit in the first quarter was mainly due to the decrease in the revenue from the company's cooperative products entering the centralized procurement-related pharmaceutical services last year.

Post date May 1, 2022 — 02:07 Post Lock

Both revenue and net profit fell sharply, and Yifan Pharmaceutical was again questioned by investors for "low efficiency"

Post date April 27, 2022 — 11:21 Post Lock

Cathay Pacific Research Selected Two-Year Holding Period Mixed Net Worth Down 3.26% Cathay Pacific

Post date April 27, 2022 — 07:40 Post Lock

Cathay Pacific Health Stock C Net Worth Down 3.26% Cathay Pacific

Post date April 27, 2022 — 07:32 Post Lock

Cathay Pacific Research Advantage Mixed Net Worth Down 3.19% Cathay Pacific

Post date April 27, 2022 — 07:31 Post Lock

Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm

Post date April 26, 2022 — 19:51 Post Lock

What are the oncology treatment concept stocks in 2022? List and ranking of leading stocks in oncology treatment

Post date April 23, 2022 — 18:03 Post Lock

Anhui: My two 100 billion counties, one is surnamed Fei, and the next may also be surnamed Fei – yqqlm

Post date April 23, 2022 — 13:06 Post Lock

Net worth of Cathay Medical and Health shares fell 3.34% Cathay Pacific_Sina Finance_Sina Network

Post date April 22, 2022 — 07:26 Post Lock

Cathay Pacific Research Advantage Mixed Net Worth Down 3.18% Cathay Pacific

Post date April 22, 2022 — 07:25 Post Lock

Yifan Pharmaceutical: The company is currently entering clinical trials of new drugs including F-652, F-899 and Duanjin Jidu Capsules.

Post date April 21, 2022 — 06:59 Post Lock

Yifan Pharmaceutical: It is difficult to predict the changes in travel restrictions due to the current epidemic

Post date April 21, 2022 — 06:58 Post Lock

Yifan Pharma: According to the cooperation agreement signed between the research product F-627 and its partners, there is basically no impact on the authorization fee at present.

Post date April 21, 2022 — 06:57 Post Lock

Yifan Pharmaceutical: The approval of F-627's marketing application in EMA is progressing smoothly

Post date April 21, 2022 — 06:57 Post Lock

Want to see more data? Registered subscribers can see all the data.